Cognitive Detection of Preclinical Alzheimer's: Validation Using Biomarkers
Language
Undefined
Purpose: To validate several novel cognitive tasks and correlate them with Alzheimer's disease biomarkers in people who are cogntitively normal or have mild cognitive impairment. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - February 16, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Bryostatin to Treat Severe Alzheimer's Disease
Language
Undefined
Purpose: To test the experimental drug bryostatin in people with moderately severe to severe Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - February 16, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
NGP 555 in Healthy Volunteers
Language
Undefined
Purpose: To test the safety and dosage of NGP 555, a potential drug to prevent Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - February 16, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
LY3002813 for Mild Cognitive Impairment or Alzheimer's Disease
Language
Undefined
Purpose: To evaluate the effect of LY3002813 in people with mild cognitive impairment or Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - February 16, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)
Language
Undefined
Purpose: To test methylphenidate (Ritalin®) as a treatment for clinically significant apathy in people with Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - February 16, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
The Depression and Memory Trial
Language
Undefined
Purpose: To determine whether duloxetine (Cymbalta®) can improve cognition in individuals with mild cognitive impairment. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - February 16, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Brain Aging in Vietnam War Veterans (DOD-ADNI)
Language
Undefined
Purpose: To study brain changes in veterans with traumatic brain injury or post traumatic stress disorder, with and without mild cognitive impairment. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - February 8, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
[18F]MNI-798 for Imaging Tau in Alzheimer's Disease
Language
Undefined
Purpose: To evaluate changes in the protein tau in the brain of people at different stages of Alzheimer's disease and in healthy volunteers. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - February 8, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Nelotanserin for Visual Hallucinations in Lewy Body Dementia
Language
Undefined
Purpose: To test the experimental drug nelotanserin for the treatment of visual hallucinations in people with Lewy body dementia. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - February 8, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Optimizing Postoperative Cognition in the Elderly
Language
Undefined
Purpose: To compare brain-wave patterns in older patients who have memory and thinking problems after surgery with brain-wave patterns in patients without such problems. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - February 8, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Natural History of Amyloid Deposition in Adults with Down Syndrome
Language
Undefined
Purpose: To assess the presence of amyloid in adults with Down syndrome. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - January 15, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials
CAD106 and CNP520 to Prevent or Delay Symptoms of Alzheimer's Disease
Language
Undefined
Purpose: To test whether two investigational drugs, CAD106 and CNP520, can prevent or delay Alzheimer's symptoms in people at high risk. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - December 29, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
GeneMatch
Language
Undefined
Purpose: To identify people interested in participating in research studies or clinical trials based in part on their genetic background. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - December 24, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Neurotrack Test Validation
Language
Undefined
Purpose: To validate Neurotrack's visual paired comparison task, aimed at early detection and monitoring of memory impairment. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - December 24, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
LY2599666 in Healthy Adults and Adults with Mild Cognitive Impairment or Alzheimer's Disease
Language
Undefined
Purpose: To test the safety and tolerability of LY2599666 in healthy adults and adults who have mild cognitive impairment or mild to moderate Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - December 24, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
